ask="7.10"
ask_size="500"
average_daily_volume="403181"
bid="5.15"
bid_size="100"
book_value="1.85"
change="+0.40"
change_from_200_day_moving_average="-0.84"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-11.62"
change_From_52_week_low="1.15"
change_in_percent="+5.97%"
close="7.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.68"
ebitda="-116.64M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-1.43"
ex_dividend_date="N/A"
float_shares="40949000"
high="7.10"
high_52_weeks="18.72"
last_trade_date="2/9/2017"
last_trade_price="7.10"
last_trade_size="32212"
last_trade_time="4:00pm"
low="6.70"
low_52_weeks="5.95"
market_capitalization="616.14M"
moving_average_200_day="7.94"
moving_average_50_day="7.16"
name="NovoCure Limited"
notes="N/A"
one_year_target_price="23.25"
open="6.70"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="-10.60%"
percent_change_from_50_day_moving_average="-0.87%"
percent_change_from_52_week_high="-62.07%"
percent_change_from_52_week_low="+19.33%"
previous_close="6.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.63"
price_per_sales="8.94"
revenue="65.03M"
shares_outstanding="86780000"
short_ratio="9.41"
stock_exchange="NMS"
symbol="NVCR"
volume="203634"
weeks_range_52="5.95 - 18.72"
